Vanguard Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112M | Buy |
|
|||||
|
2025
Q1 | $60.2M | Buy |
|
|||||
|
2024
Q4 | $68.3M | Buy |
|
|||||
|
2024
Q3 | $81.1M | Sell |
|
|||||
|
2024
Q2 | $94.4M | Buy |
|
|||||
|
2024
Q1 | $112M | Buy |
|
|||||
|
2023
Q4 | $99.6M | Buy |
|
|||||
|
2023
Q3 | $69.8M | Buy |
|
|||||
|
2023
Q2 | $86M | Buy |
|
|||||
|
2023
Q1 | $67.1M | Buy |
|
|||||
|
2022
Q4 | $58.6M | Buy |
|
|||||
|
2022
Q3 | $93.8M | Buy |
|
|||||
|
2022
Q2 | $80.4M | Buy |
|
|||||
|
2022
Q1 | $76.4M | Buy |
|
|||||
|
2021
Q4 | $25.5M | Sell |
|
|||||
|
2021
Q3 | $40.4M | Buy |
|
|||||
|
2021
Q2 | $42.7M | Buy |
|
|||||
|
2021
Q1 | $31.6M | Buy |
|
|||||
|
2020
Q4 | $38.3M | Sell |
|
|||||
|
2020
Q3 | $32.7M | Buy |
|
|||||
|
2020
Q2 | $24.5M | Buy |
|
|||||
|
2020
Q1 | $7.88M | Buy |
|
|||||
|
2019
Q4 | $10.4M | Buy |
|
|||||
|
2019
Q3 | $3.37M | Buy |
|
|||||
|
2019
Q2 | $3.82M | Buy |
|
|||||
|
2019
Q1 | $2.3M | Buy |
|
|||||
|
2018
Q4 | $1.72M | Buy |
|
|||||
|
2018
Q3 | $2.31M | Buy |
|
|||||
|
2018
Q2 | $2.87M | Buy |
|
|||||
|
2018
Q1 | $1.89M | Buy |
|
|||||
|
2017
Q4 | $405K | Sell |
|
|||||
|
2017
Q3 | $309K | Buy |
|
|||||
|
2017
Q2 | $273K | Buy |
|